Home › Liver Diseases › Indiana
Liver Diseases clinical trials in Indiana
6 studies for Liver Diseases are looking for participants at sites in Indiana.
Cities in Indiana
Study of Resmetirom in Children and Adolescents With MASH
- Riley Hospital for Children at IU Health, Indianapolis
RecruitingPhase 2
Ages 6 to 17 · All sexes · Updated Sep 11, 2026 · NCT07763015A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Digestive Research Alliance of Michiana, South Bend
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 9, 2026 · NCT07288138A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Hammond
- 89bio Clinical Study Site, New Albany
- 89bio Clinical Study Site, South Bend
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 3, 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Hammond
- 89bio Clinical Study Site, New Albany
- 89bio Clinical Study Site, South Bend
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06419374DILIN - Prospective Study
- Indiana University, Indianapolis
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older · All sexes · Updated Apr 8, 2026 · NCT00345930A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
- Indiana University Division of Gastroenterolgy and Hepatology, Indianapolis
Recruiting
Ages 18 and older · All sexes · Updated Oct 24, 2025 · NCT05733832From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.